VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Wednesday, January 7, 2026
Stock Comparison
Games Workshop Group PLC vs Pfizer Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Games Workshop Group PLC
GAW · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Games Workshop Group PLC's moat claims, evidence, and risks.
View GAW analysisPfizer Inc.
PFE · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Games Workshop Group PLC leads (87 / 100 vs 58 / 100 for Pfizer Inc.).
- Segment focus: Games Workshop Group PLC has 2 segments (91.5% in Core (Warhammer miniatures & hobby products)); Pfizer Inc. has 5 segments (47.4% in Primary Care).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: Games Workshop Group PLC has 8 moat types across 4 domains; Pfizer Inc. has 8 across 3.
Primary market context
Games Workshop Group PLC
Core (Warhammer miniatures & hobby products)
Tabletop miniature wargaming and related hobby products
Global
Hobbyists/collectors (B2C) plus independent retailers (B2B)
IP owner + designer/manufacturer + distributor + direct-to-consumer retail
91.5%
Pfizer Inc.
Primary Care
Branded primary care medicines and vaccines (incl. cardiovascular, migraine, pneumococcal/RSV/COVID-19)
Global
Healthcare providers, payers/PBMs, pharmacies/wholesalers, and government procurement
Innovator biopharma (R&D + manufacturing + commercialization)
47.4%
Side-by-side metrics
Moat coverage
Shared moat types
Games Workshop Group PLC strengths
Pfizer Inc. strengths
Segment mix
Games Workshop Group PLC segments
Full profile >Core (Warhammer miniatures & hobby products)
Oligopoly
Licensing (Warhammer IP)
Monopoly
Pfizer Inc. segments
Full profile >Primary Care
Oligopoly
Specialty Care
Oligopoly
Oncology
Competitive
Pfizer CentreOne
Competitive
Pfizer Ignite
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.